4/A: Chemed Corp Executive Vice President Nicholas Westfall Amends Filing After Stock Sale
SEC Filing (Form 4/A)
Nicholas Westfall, Executive Vice President of Chemed Corp, amended a previous filing to report a sale of 2,000 shares of capital stock at an average price of $561.58.
Summary
- Nicholas Westfall, an Executive Vice President at Chemed Corp, filed an amendment to a previous Form 4.
- The amendment concerns a transaction that occurred on July 30, 2024.
- Westfall sold 2,000 shares of Chemed Corp capital stock at a weighted average price of $561.58.
- Following the transaction, Westfall directly owns 6,109 shares of Chemed Corp capital stock.
Sentiment
Score: 5
Explanation: The document is a regulatory filing detailing a stock sale by an executive, which is neutral in sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence.
Stakeholder Impact
- The stock sale by an executive may have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/30/2024 | Date of the stock sale transaction. |
| 07/31/2024 | Date of original filing. |
| 08/01/2024 | Date of amended filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.